论文部分内容阅读
近年来白血病,特别是急性白血病的疗效显著提高,90％以上的儿童白血病可完全缓解(CR),达到可望冶愈的阶段,成年人白血病的CR率为70～80％,尚未达到可望治愈的阶段。为进一步提高疗效,目前正致力于各种药剂的开发工作,对于迄今频繁使用的抗白血病药物,通过改变其用法、用量,可望获得新的疗效。本文简述最近令人注意的抗白血病药、正在进行临床试验的新药,以及使用这些制剂的治疗方法。
In recent years, the curative effect of leukemia, especially acute leukemia, has been significantly improved. More than 90% of children with leukemia can be completely relieved (CR), reaching the stage of hopeful recovery. The CR rate of adult leukemia is 70-80%, which is not yet expected to reach The stage of healing. In order to further improve the curative effect, it is currently working on the development of various pharmaceuticals. For the anti-leukemia drugs that have been frequently used so far, new therapeutic effects can be obtained by changing their usage and dosage. This article briefly describes the recently noted anti-leukemia drugs, new drugs that are undergoing clinical trials, and treatments that use these formulations.